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A commentary on
TERRA expression levels do not correlate 
with telomere length and radiation sensi-
tivity in human cancer cell lines
by Smirnova A, Gamba R, Khoriauli L, Viteli 
V, Nergadze SG,Giulotto E. Front Oncol 
(2013) 3:115. doi: 10.3389/fonc.2013.00115
We read with great interest the Research 
Article by Smirnova et al. (1) in which sets 
of isogenic subclones isolated from human 
cancer cell lines were used to investigate 
the impact of telomere length on telomeric 
repeat-containing RNA (TERRA) expres-
sion. The first conclusion from this study, 
i.e., that telomere length does not impact 
on TERRA expression, was based on results 
obtained from a combination of Southern 
(telomeres) and northern (TERRA) blots. 
Using the same 32P-α[dCTP]-labeled telo-
meric probe, the authors, on one hand, 
measured telomere length by evaluating the 
molecular weight range in which TTAGGG 
signals were detected, and, on the other 
hand, measured TERRA expression levels 
by quantifying radioactive signals com-
ing from hybridization of the probe with 
UUAGGG repeats. We believe, however, 
that the latter approach is misleading when 
used to quantify TERRA expression in cells 
with distinct telomere lengths for two main 
reasons. First, TERRA transcript length is 
naturally increased upon elongation of its 
template DNA, the telomeric repeats [(2); 
Figures 1A,B], and therefore northern blots 
measure UUAGGG content rather than the 
number of TERRA molecules. Second, the 
transfer efficiency of TERRA onto nylon 
membranes is drastically reduced upon 
increase in molecule length. Hence, if 
alkaline treatment is omitted after electro-
phoresis, long TERRA molecules simply do 
not transfer (Figures 1B,C). A drawback 
of alkaline treatment however explaining 
why this is usually not applied for north-
ern blots is that it releases RNA from the 
gel (Figures 1B,C), making quantifications 
rather difficult. Smirnova et al. (1) do not 
appear to have included an alkaline treat-
ment step as, despite high differences in 
telomere length, notably between HeLa 
parental cells (7 kb) and cells overexpress-
ing telomerase (50 kb), TERRA profiles 
were similar (Figure 1 of their article). 
Most probably, a dot-blot analysis of total 
RNA would have revealed much higher 
levels of UUAGGG repeats in HeLa cells 
overexpressing telomerase. However, here 
too, data must be carefully interpreted as, 
despite higher UUAGGG repeat content, 
the number of TERRA molecules may 
still be lower compared to the isogenic cell 
line with shorter telomeres. This is easily 
explained as follows: if telomere length 
increases from 7 to 50 kb, and provided that 
UUAGGG tract length mirrors that of the 
TTAGGG tract, UUAGGG repeats may be 
up to sevenfold more abundant in cells with 
longer telomeres. If, as we reported previ-
ously (2), increased telomere length down-
regulates telomere transcription, UUAGGG 
repeats may still be more abundant if the 
fold-reduction in telomere transcription 
does not exceed the fold-increase in tel-
omere length. Following this argumenta-
tion, in the HeLa cell example given above, 
with a twofold reduction in the number of 
TERRA molecules transcribed from longer 
telomeres and no change in TERRA sta-
bility, the resulting number of UUAGGG 
repeats would be 3.5-fold higher, although 
molecule abundance would be decreased 
by twofold.
We briefly mentioned RNA dot-blot 
as another tool to monitor total cellular 
amounts of UUAGGG repeats. This, again, 
does not allow quantification of TERRA 
molecule abundance and should only be 
used to compare TERRA expression levels 
across cell lines if their respective telomere 
lengths are properly evaluated. TERRA-FISH 
(Fluorescent In Situ Hybridization), first 
described by Azzalin et al. (3), represents 
another analytical tool to monitor TERRA 
abundance at telomeres but does not allow 
quantification of all TERRA species as only 
part of them are located at  telomeres (4). 
Hence,  quantification of TERRA by RT-PCR 
(Reverse  Transcriptase-PCR) targeting sub-
telomeric parts of the RNA molecules, as 
initiated by Azzalin et al. (3), appears to be 
more appropriate to assess TERRA expres-
sion independently of molecule length 
(Figures 1D,E). In this view, and fitting with 
our proposal that telomere transcription 
decreases upon elongation, close examina-
tion of Figure 3 data from Smirnova et al. 
(1) revealed that there might be an inverse 
correlation between telomere length and the 
number of TERRA molecules measured by 
quantitative RT-PCR in various HeLa sub-
clones. However, because the cellular systems 
used in Smirnova et al. (1) are different from 
the ones described in Arnoult et al. (2), we 
cannot exclude that differences may exist 
between these two  studies regarding telomere 
length-dependent  repression of TERRA.
Altogether, it is clear that the tools cur-
rently available to monitor TERRA are not 
equivalent in terms of qualitative/quantita-
tive information they provide and research-
ers should bear this in mind to properly 
interpret their data. Besides, one should 
be aware that northern blot experiments 
require to account for the various transfer 
efficiencies of short vs long TERRA mol-
ecules. In the future, it would be interesting 
to design additional subtelomeric primers 
for qRT-PCR measurement of TERRA mol-
ecules produced from single telomeres and 
in various species, as we believe that this 
represents a method of choice for quanti-
fication of TERRA expression. One should 
keep in mind however that qRT-PCR-based 
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measurements of TERRA are also likely to 
detect very short molecules that may arise 
from incomplete transcription or other pro-
cesses, such as TERRA degradation.
Acknowledgments
This work was supported by the Belgian 
Fonds National de la Recherche Scientifique 
and by a fellowship from the Fonds pour la 
 formation à la Recherche dans l’Industrie 
et dans l’Agriculture (FRIA 1.E127.10) (to 
Amandine Van Beneden). We are grateful to 
the de Duve Institute for constant support 
and to J. Boros for critical reading of the 
manuscript.
RefeRences
 1. Smirnova A, Gamba R, Khoriauli L, Viteli V, 
Nergadze SG, Giulotto E. TERRA expression levels 
do not correlate with telomere length and radiation 
sensitivity in human cancer cell lines. Front Oncol 
(2013) 3:115. doi: 10.3389/fonc.2013.00115
 2. Arnoult N, Van Beneden A, Decottignies A. 
Telomere length regulates TERRA levels through 
increased trimethylation of telomeric H3K9 and 
HP1α. Nat Struct Mol Biol (2012) 19:948–56. doi: 
10.1038/nsmb.2364
 3. Azzalin C, Reichenbach P, Khoriauli L, Giuletto E, 
Lingner J. Telomeric repeat-containing RNA and 
RNA surveillance factors at mammalian chro-
mosome ends. Science (2007) 318:798–801. doi: 
10.1126/science.1147182
 4. Porro A, Feuerhahn S, Reichenbach P, Lingner J. 
Molecular dissection of telomeric repeat-containing 
RNA biogenesis unveils the presence of distinct and 
multiple regulatory pathways. Mol Cell Biol (2010) 
30:4808–17. doi: 10.1128/MCB.00460-10
Received: 11 June 2013; accepted: 22 June 2013; published 
online: 08 July 2013.
Citation: Van Beneden A, Arnoult N and Decottignies A 
(2013) Telomeric RNA expression: length matters. Front. 
Oncol. 3:178. doi: 10.3389/fonc.2013.00178
This article was submitted to Frontiers in Cancer 
Molecular Targets and Therapeutics, a specialty of 
Frontiers in Oncology.
Copyright © 2013 Van Beneden, Arnoult and Decottignies. 
This is an open-access article distributed under the terms of 
the Creative Commons Attribution License, which permits 
use, distribution and reproduction in other forums, provided 
the original authors and source are credited and subject to 
any copyright notices concerning any third-party graphics etc.
Figure 1 | (A) Southern blot analysis of telomere length in HT1080 parental (S) 
or telomerase-overexpressing (L) cells and in HeLa parental (S) or a subclone with 
long telomeres (L) (2). MW, molecular weight. (B) Northern blot analysis of 
TERRA and ACTB (control) in the four cell lines described in (A), with or without 
alkaline treatment of the agarose gel prior to transfer. *High molecular weight 
molecules that only transfer after alkaline treatment. (C) Quantification from 
(B). (D) Cartoon representing human chromosome ends and subtelomeric 
primers (arrowheads) that are used to quantify TERRA molecules from various 
chromosome ends by qRT-PCR. (e) qRT-PCR analyses of TERRA molecules 
transcribed from either 1q/2q/10q/13q or 15q in the four cell lines described in 
(A). Values were normalized to parental cell lines and error bars represent SD. All 
methods used here have been described in Arnoult et al. (2).
